TREANDA (Cephalon, Inc.)


Welcome to the PulseAid listing for the TREANDA drug offered from Cephalon, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cephalon, Inc.
NON-PROPRIETARY NAME: Bendamustine Hydrochloride
SUBSTANCE NAME: BENDAMUSTINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Alkylating Activity [MoA],Alkylating Drug [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-01-05
END MARKETING DATE: 0000-00-00


TREANDA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTREANDA from Cephalon, Inc.
LABELER NAME: Cephalon, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 25(mg/5mL)
START MARKETING DATE: 2010-01-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63459-390_f0c07122-a1f6-43ab-820b-231864f51983
PRODUCT NDC: 63459-390
APPLICATION NUMBER: NDA022249

Other BENDAMUSTINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cephalon, Inc.TREANDA
Teva Pharmaceuticals USA, Inc.BENDEKA